Enanta Pharmaceuticals (ENTA) Receivables - Net (2012 - 2026)
Enanta Pharmaceuticals' Receivables - Net came in at $6.53 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 21.6% from $8.33 million a year earlier and down 16.3% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Receivables - Net (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Receivables - Net was $6.88 million, up 3.6% from FY2024.
- Receivables - Net carries a five-year compound annual growth rate of -21.8% (FY2020 to FY2025).
- Going back by fiscal year, Receivables - Net was $6.65 million in FY2024 (-22.8%), $8.61 million in FY2023 (-57.6%), $20.32 million in FY2022 (-13.8%) and $23.58 million in FY2021 (+0.4%).
- The fiscal Q3 2026 figure represents the lowest quarterly Receivables - Net since fiscal Q4 2014.
- Year-over-year, Receivables - Net increased in four of the last eight quarters, with an average decline of 4.0%.
- The fastest year-over-year change in Receivables - Net over five years came in fiscal Q2 2026 (growth of 15.0%), and the weakest in fiscal Q1 2024 (a decline of 63.8%).
- Business Quant data shows ENTA's Receivables - Net at $7.81 million (Q2 2026), $8.49 million (Q1 2026) and $6.88 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Enanta Pharmaceuticals | 367.20 Mn | -360.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.53 Mn |
| Mar 31, 2026 | 7.81 Mn |
| Dec 31, 2025 | 8.49 Mn |
| Sep 30, 2025 | 6.88 Mn |
| Jun 30, 2025 | 8.33 Mn |
| Mar 31, 2025 | 6.79 Mn |
| Dec 31, 2024 | 7.72 Mn |
| Sep 30, 2024 | 6.65 Mn |
| Jun 30, 2024 | 8.18 Mn |
| Mar 31, 2024 | 7.76 Mn |
| Dec 31, 2023 | 8.17 Mn |
| Sep 30, 2023 | 8.61 Mn |
| Jun 30, 2023 | 18.89 Mn |
| Mar 31, 2023 | 17.80 Mn |
| Dec 31, 2022 | 22.59 Mn |
| Sep 30, 2022 | 20.32 Mn |
| Jun 30, 2022 | 19.48 Mn |
| Mar 31, 2022 | 18.72 Mn |
| Dec 31, 2021 | 27.65 Mn |
| Sep 30, 2021 | 23.58 Mn |
API Access
Enanta Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();